Live to tell

Natalie Cole has weathered the ups and downs of the music industry and come out singing, writes Harriet Cunningham.

You have to admit it. Natalie Cole is a survivor. The award-winning singer, songwriter, actor and performer once tried to fly out of a window under the influence of LSD. She cooked crack cocaine as a hotel burnt around her. During a 10-year battle with addiction she lost a marriage, money and, nearly, her life. And throughout her career, which spans four decades and encompasses multiple hit singles and nine Grammy awards, she has been haunted by the legacy of her father, Nat King Cole, the legendary jazz singer who died from lung cancer when she was just 15.

However, in 2009, just as she was preparing a tour to promote the new album, her past came screaming back to haunt her. She was diagnosed with hepatitis C during a routine check-up and advised that she must embark on a course of chemotherapy to halt the disease.

Six months into the treatment, she collapsed from kidney failure. She received a kidney transplant that year and was back on stage three months later. Cole is about to arrive in Australia, appearing with the Sydney, Queensland, Melbourne and

To read this full article CLICK HERE

Bali tattoo and HIV transmission scare

Tourists who have gotten themselves tattooed or pierced whilst in Bali are being warned to seek medical advice after a Western Australian man reportedly contracted HIV during a recent holiday trip.

Australian health officials are urging travelers to be careful about getting tattoos or piercings in developing countries as the regulations and codes of practice don't necessarily comply with Australia's. The US Centers for Disease Control and Prevention (CDC) warns that to avoid infections from HIV and viral hepatitis, individuals should not share needles for tattoos, body piercings, or other injections.

The WA Health notified Commonwealth authorities last week after the WA resident undertook a blood test when he returned from Indonesia. The victim's age and sex and details of where the tattoo was obtained in Bali have not been released.

To read this full article CLICK HERE

New drug hope for HIV and hepatitis C

New drugs to treat HIV and hepatitis C could be developed after a finding by Melbourne scientists.

The breakthrough means researchers now have a better understanding of how the deadly viruses spread. The University of Melbourne led teams from around the world, and for the first time was able to map the structure of an enzyme in the body, which helps infection replicate and spread.

Associate Professor Spencer Williams said the findings significantly advanced understanding of how the viruses reproduce.

"We think it has got broad significance and we think it's an important achievement in the area," he said.

To read this full article CLICK HERE

Hep C Vaccine Shows Promise In First Trial

An experimental vaccine against the chronic liver disease hepatitis C has shown promising results in its first clinical trial in humans, say researchers from the University of Oxford, UK, who write about their findings in the 4 January online issue of Science Translational Medicine. However, they caution there is still a long way to go before we have an effective vaccine ready for clinical use.

There is currently no vaccine for hepatitis C virus (HCV), a major pathogen transmitted through the blood that infects some 170 million people around the world. The infection can remain hidden without showing symptoms for years, and many people don't know they are infected.

The disease is now the main reason people in Western countries have liver transplants.

To read this full article CLICK HERE

Hepatitis C Psychological Support Study Information

The School of Psychology (University of Adelaide) and the Department of Gastroenterology and Hepatology (Royal Adelaide Hospital) have commenced a research study exploring the desire for psychological support in people living with chronic hepatitis C.

The psychological burden of chronic hepatitis C is considerable and particularly evident in high rates of depression and anxiety in those suffering from this disease. This psychiatric morbidity diminishes quality of life, aggravates perceived physical symptomatology and reduces rates of antiviral treatment commencement, adherence and clearance.

The survey takes 10 to 20 minutes to complete and includes sections on demographic information, desire for psychological support, history of psychological support, disease and treatment characteristics, psychological symptomatology and access to social support.

To access this survey CLICK HERE